HKSE · 0722.HK
UMP Healthcare Holdings Limited
HK$0.37HK$0.00 (0.0%)
UMP Healthcare Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 27.0% below the high.
Loading market information…
HKSE · 2293.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:20 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Bamboos Health Care Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 30.17% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Bamboos Health Care Holdings Limited’s forward annual dividend is HK$0.03 per share, paid semi-annual. The forward yield is 7.41% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Bamboos Health Care Holdings Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Bamboos Health Care Holdings Limited functions as an investment holding entity primarily dedicated to furnishing healthcare workforce solutions throughout Hong Kong. Its extensive array of services includes vital support for medical facilities and tailored private nursing provisions. Beyond these core offerings, the company also engages in providing marketing and consultancy, fostering the advancement and deployment of technological applications, and operating its own chain of aesthetic clinics. Catering to a diverse clientele, Bamboos Health Care assists both private individuals and organizational clients such as hospitals, social welfare organizations, and various clinics. Founded in 2009, the firm's main offices are located in Tsim Sha Tsui, Hong Kong.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:36 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$0.37HK$0.00 (0.0%)
UMP Healthcare Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 27.0% below the high.
HK$0.76+HK$0.01 (+0.66%)
Human Health Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 14.61% below the high.
HK$0.87+HK$0.02 (+2.35%)
Regent Pacific Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.69% below the high.
HK$0.25+HK$0.00 (+0.82%)
Tycoon Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 36.36% below the high.
HK$0.11+HK$0.00 (+0.91%)
Shenzhen Neptunus Interlong Bio-technique Company Limited’s quoted price sits in the lower half of its reported 52-week range, 37.99% below the high.
HK$0.03HK$0.00 (0.0%)
Tai United Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 44.44% below the high.
HK$0.05HK$0.00 (0.0%)
Extrawell Pharmaceutical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 55.65% below the high.
HK$0.23-HK$0.01 (-4.17%)
Joyzyme Group Limited’s quoted price sits in the lower half of its reported 52-week range, 69.33% below the high.
